Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage

Neurobiology of Disease

Volumn 70, Issue , 2014, Pages 245-251

  Lu, Xiangping ^a   Chen Roetling, Jing ^a   Regan, Raymond F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Heme; Heme oxygenase; Preconditioning; Stroke

Indexed keywords

COLLAGENASE; EVANS BLUE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HEME OXYGENASE 1; HEMIN; PROTOPORPHYRIN TIN; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER INJURY; BODY MOVEMENT; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN SLICE; CELL LOSS; CELL VIABILITY; CONVALESCENCE; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG POTENCY; EXTRAVASATION; FEMALE; LOCOMOTION; LOW DRUG DOSE; MALE; MEMBRANE PERMEABILITY; MOUSE; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPEATED DRUG DOSE; STRIATE CORTEX; TRANSLATIONAL RESEARCH; ANIMAL; BRAIN EDEMA; CAPILLARY PERMEABILITY; CELL SURVIVAL; CEREBRAL HEMORRHAGE; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CAPILLARY PERMEABILITY; CELL SURVIVAL; CEREBRAL HEMORRHAGE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; HEME OXYGENASE-1; HEMIN; MALE; MEMBRANE PROTEINS; MICE; NEUROPROTECTIVE AGENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904874077     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.06.005     Document Type: Article

References (49)

1. Abraham N.G., et al. Human heme oxygenase: cell cycle-dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells. J. Cell. Biochem. 2003, 90:1098-1111.
2. Anderson K.E., et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann. Intern. Med. 2005, 142:439-450.
3. Attuwaybi B.O., et al. Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury. J. Surg. Res. 2004, 118:53-57.
4. Balla G., et al. Ferritin: a cytoprotective strategem of endothelium. J. Biol. Chem. 1992, 267:18148-18153.
5. Balla J., et al. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9285-9289.
6. Belcher J.D., et al. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J. Clin. Invest. 2006, 116:808-816.
7. Bunn H.F., Jandl J.H. Exchange of heme along hemoglobins and between hemoglobin and albumin. J. Biol. Chem. 1968, 243:465-475.
8. Chen L., et al. Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J. Neurosurg. 2011, 114:1159-1167.
9. Chen-Roetling J., et al. Effect of iron chelators on methemoglobin and thrombin preconditioning. Transl Stroke Res. 2012, 3:452-459.
10. Chen-Roetling J., et al. A rapid fluorescent method to quantify neuronal loss after experimental intracerebral hemorrhage. J. Neurosci. Methods 2013, 216:128-136.
11. Chok M.K., et al. Renoprotective potency of heme oxygenase-1 induction in rat renal ischemia-reperfusion. Inflamm. Allergy Drug Targets 2009, 8:252-259.
12. Clark J.E., et al. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H643-H651.
13. Correa-Costa M., et al. Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment. PLoS One 2012, 7:e49569.
14. Demirogullari B., et al. A comparative study of the effects of hemin and bilirubin on bilateral renal ischemia reperfusion injury. Nephron Exp. Nephrol. 2006, 103:e1-e5.
15. Desbuards N., et al. Heme oxygenase-1 inducer hemin attenuates the progression of remnant kidney model. Nephron Exp. Nephrol. 2009, 113:e35-e44.
16. Dhar G.J., et al. Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission. Acta Med. Scand. 1978, 203:437-443.
17. Habtezion A., et al. Panhematin provides a therapeutic benefit in experimental pancreatitis. Gut 2011, 60:671-679.
18. Hangaishi M., et al. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem. Biophys. Res. Commun. 2000, 279:582-588.
19. Holzen J.P., et al. Influence of heme oxygenase-1 on microcirculation after kidney transplantation. J. Surg. Res. 2008, 148:126-135.
20. Huang F.P., et al. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J. Neurosurg. 2002, 96:287-293.
21. Jadhav A., et al. Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am. J. Physiol. Renal Physiol. 2009, 296:F521-F534.
22. Kang K., et al. Heme oxygenase 1 modulates thrombomodulin and endothelial protein C receptor levels to attenuate septic kidney injury. Shock 2013, 40:136-143.
23. Keep R.F., et al. Blood-brain barrier function in intracerebral hemorrhage. Acta Neurochir. Suppl. 2008, 105:73-77.
24. Kim J.H., et al. Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway. J. Am. Soc. Nephrol. 2006, 17:1373-1381.
25. Koeppen A.H., et al. Heme oxygenase in experimental intracerebral hemorrhage: the benefit of tin-mesoporphyrin. J. Neuropathol. Exp. Neurol. 2004, 63:587-597.
26. Letarte P.B., et al. Hemin: levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth muscle cells. J. Neurosurg. 1993, 79:252-255.
27. Li R.C., et al. Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J. Cereb. Blood Flow Metab. 2009, 29:953-964.
28. Lin Q., et al. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 2007, 282:20621-20633.
29. Linden I.B., et al. Fate of haem after parenteral administration of haem arginate to rabbits. J. Pharm. Pharmacol. 1987, 39:96-102.
30. Lindenblatt N., et al. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler. Thromb. Vasc. Biol. 2004, 24:601-606.
31. Liu D.Z., et al. Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons. Neurobiol. Dis. 2008, 30:201-211.
32. Maclellan C.L., et al. Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies. J. Cereb. Blood Flow Metab. 2006, 26:1031-1042.
33. Maclellan C.L., et al. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J. Cereb. Blood Flow Metab. 2008, 28:516-525.
34. Mense S.M., Zhang L. Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res. 2006, 16:681-692.
35. Nakamura T., et al. Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice. J. Cereb. Blood Flow Metab. 2004, 24:487-494.
36. Ogawa T., et al. Protein therapy using heme-oxygenase-1 fused to a polyarginine transduction domain attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2011, 31:2231-2242.
37. Ono S., et al. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J. Neurosurg. 2002, 96:1094-1102.
38. Regan R.F., et al. Heme oxygenase-1 induction protects murine cortical astrocytes from hemoglobin toxicity. Neurosci. Lett. 2000, 282:1-4.
39. Robinson S.R., et al. Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke. Redox Rep. 2009, 14:228-235.
40. Suzuki S., et al. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J. Clin. Invest. 1999, 104:59-66.
41. Takizawa S., et al. Induction of heme oxygenase protein protects neurons in cortex and striatum, but not hippocampus, against transient forebrain ischemia. J. Cereb. Blood Flow Metab. 1998, 18:559-569.
42. Tenhunen R., et al. Haem arginate: a new stable haem compound. J. Pharm. Pharmacol. 1987, 39:780-786.
43. Uyama O., et al. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cereb. Blood Flow Metab. 1988, 8:282-284.
44. Wang J., Doré S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 2007, 130:1643-1652.
45. Xi G.H., et al. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J. Neurosurg. 1998, 89:991-996.
46. Xue H., et al. Heme oxygenase-1 induction by hemin protects liver cells from ischemia/reperfusion injury in cirrhotic rats. World J. Gastroenterol. 2007, 13:5384-5390.
47. Yamauchi T., et al. Hemin induces heme oxygenase-1 in spinal cord vasculature and attenuates barrier disruption and neutrophil infiltration in the injured murine spinal cord. J. Neurotrauma 2004, 21:1017-1030.
48. Zhang B., et al. Effects of heme oxygenase 1 on brain edema and neurologic outcome after cardiopulmonary resuscitation in rats. Anesthesiology 2008, 109:260-268.
49. Zhong W., et al. Hemin exerts multiple protective mechanisms and attenuates dextran sulfate sodium-induced colitis. J. Pediatr. Gastroenterol. Nutr. 2010, 50:132-139.